Personal experience with prolonged-action fluphenazine
Król, K.; Krystof, J.
Psychiatria Polska 8(2): 149-155
1974
ISSN/ISBN: 0033-2674 PMID: 4830322 Document Number: 80696
Document emailed within 1 workday
Related Documents
Koślacz, A.; Popkowska, N.; Kulesza, E.; Lysikowska-Prokop, L.; Marmurowska-Michalowska, H.; Perzyński, J. 1977: Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment Psychiatria Polska 11(2): 159-164Galdo Seco, A.; Carazo de la Fuente, M.; Cañuelo Espejo, S. 1970: Prolonged pharmacological sleep; personal experience Revista Espanola de Anestesiologia y Reanimacion 17(3): 563-569
Mikunis, R.I.; Monastyrskiĭ, I.I.; Zhebel', V.N.; Serkova, V.K.; Bogach, N.T. 1987: Experience with the use of nitroderm--a prolonged-action nitroglycerin preparation Kardiologiia 27(3): 99-101
Small, J.G.; Kellams, J. 1974: Early hospital experience with fluphenazine decanoate Diseases of the Nervous System 35(10): 453-456
Náhunek, K.; Rodová, A.; Svestka, J. 1970: Clinical experience with fluphenazine decanoate in psychoses Activitas Nervosa Superior 12(1): 47-49
Grosser, H.H. 1970: Experience of psychiatric management of schizophrenia with fluphenazine decanoate Diseases of the Nervous System 31(Suppl): 32-36
Bartolo, M.; Di Folca, A.; Ricci, S. 1981: Plethysmographic researches on the beginning and duration of the pharmacological action of an isosorbide dinitrate drugs with prolonged action Giornale Italiano di Cardiologia 11(9): 1283-1287
Tsai, J.C.; Knoblich, G.; Sebanz, N. 2010: From action expertise to shared action plans: Inclusion of non-controlled actions at the intra- and inter-personal level International Journal of Psychophysiology 77(3): 332-333
Remiszewski, P.; Słodkowska, J.; Pawlicka, L.; Płodziszewska, M.; Załeska, J.; Dorosz, P.; Rowińska-Zakrzewska, E. 1998: Our experience in bronchiolitis obliterans organising pneumonia (BOOP): personal experience Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 5(30): 372-376
Lelakowski, J.; Małecka, B.; Bednarek, J.; Sadowski, J.; Sedziwy, L. 1996: The role of prolonged cardiac pacing in management of secondary bradyarrhythmias based on personal experiences Wiadomosci Lekarskie 49(7-12): 116-123
Artese, R.; De Laszlo, M.H.; Molocznik, I.; Varela, J.; Guitelman, A.; Brussino, M.; Dickmann, G.H.; Montes, M.E. 1971: Pharmacodynamic evaluation of synthetic prolonged-action ACTH on the adrenal function of patients with hypothalamo-pituitary pathology. Comparative study of synthetic ACTH and extra-delayed-action gel Prensa Medica Argentina 57(46): 2088-2097
Simon, P. 1970: An injectable contraceptive with prolonged action Therapeutique 46(10): 1029-1032
Gómez, M.A. 1997: Personal destiny: determination, will, and action Boletin de la Asociacion Medica de Puerto Rico 89(1-3): 41-46
Massey, L.F.; Escobedo, V. 1989: Anhydrous theophylline in micropellets with prolonged action in asthmatic children Revista Alergia Mexico 36(6): 245-251
Klimenkov, A.A.; Smolianskaia, A.Z.; Iskenderov, F.I.; Gavrilova, T.N.; Petrova, E.N. 1992: Prolonged antibacterial action of synthetic suture materials containing gentamicin Antibiotiki i Khimioterapiia 37(1): 39-41
Chodkowska-Granicka, B.; Michalski, K.; Surowiecki, J.; Pawlak, E.; Trojanowska, Z. 1970: Obtaining of prolonged action of drugs based on insoluble matrix Acta Poloniae Pharmaceutica 27(3): 285-290
Mayer, M.; Camenen, X. 1957: An estrogen of prolonged action; estradiol cyclopentylpropionate; clinical observations La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 33(6): 327-332
Gueurten, D.; Dubois, D.M. 1981: Mathematical model of the release of a prolonged-action form of indomethacin Pharmaceutica Acta Helvetiae 56(9-10): 296-301
Sporova, N.A.; Kozlova, L.P.; Zubareva, T.V.; Cherkasova, I.N. 1976: Effectiveness of treatment of primary glaucoma with prolonged-action pilocarpine Oftalmologicheskii Zhurnal 31(1): 35-37
Spitzer, R. 1999: A personal experience Seminars for Nurse Managers 7(3): 99-100